For the healthcare sector, the days of the billion-dollar blockbuster are just getting started. With new advances in biotech discovery, innovation is driving cash flows and dividends at many of the major pharmas – and that includes our latest pick for the Best Dividend Capture Stocks List!
Our pick is one of the largest pharmaceutical companies on the planet, with a large portfolio of key cancer-fighting medicines and other advanced drugs. Thanks to swift sales of these medicines and the cash flows they provide, our pick has continued to plow heavily into new sources of innovation, partnerships and smart M&A.
Because of its long history of payout and cash flow growth, our pick is also a great dividend capture play. A dividend capture strategy involves buying a stock before its ex-dividend date and then selling it after it has recovered the payout. With an ex-dividend date of Thursday, June 30, our pick is primed for the strategy, as is evident from its historical track record of a recovery period within an average of 7.8 days after going ex-dividend.
For investors looking for a quick total return of income and capital appreciation, our latest healthcare pick has the potential to give you what you need.
You can check out the Best Dividend Capture Stocks List to explore all the stocks.
